5370-36-5 Usage
Uses
Used in Pharmaceutical Industry:
1-Ethylpyrrolidine-3-carboxylic acid is used as a building block for the synthesis of various drugs and pharmaceutical compounds. Its unique structure allows it to be incorporated into a wide range of molecules, contributing to the development of new and innovative medications.
Used in Treatment of Neurological and Psychiatric Disorders:
1-Ethylpyrrolidine-3-carboxylic acid has been studied for its potential role in the treatment of neurological and psychiatric disorders. Its ability to interact with specific biological targets makes it a promising candidate for therapeutic applications in these areas.
Used as a Chiral Catalyst in Organic Chemical Reactions:
In addition to its pharmaceutical applications, 1-Ethylpyrrolidine-3-carboxylic acid is also used as a chiral catalyst in organic chemical reactions. Its unique stereochemistry enables it to selectively catalyze certain reactions, leading to the production of specific enantiomers or isomers, which is crucial in the synthesis of various chemical compounds and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 5370-36-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,3,7 and 0 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5370-36:
(6*5)+(5*3)+(4*7)+(3*0)+(2*3)+(1*6)=85
85 % 10 = 5
So 5370-36-5 is a valid CAS Registry Number.
InChI:InChI=1/C7H13NO2/c1-2-8-4-3-6(5-8)7(9)10/h6H,2-5H2,1H3,(H,9,10)
5370-36-5Relevant academic research and scientific papers
METHODS OF TREATING LIVER DISEASES
-
, (2014/05/24)
The invention provides tricyclic compounds and their use in treating liver disorders, such as non-alcoholic steatohepatitis and related disorders (e.g., fibrosis). The compounds are contemplated to have activity against methionyl aminopeptidase 2.
TRICYCLIC COMPOUNDS FOR USE IN THE TREATMENT AND/OR CONTROL OF OBESITY
-
Paragraph 00673-00676, (2014/05/24)
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against me
PARTIALLY SATURATED TRICYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME
-
, (2012/12/13)
The invention provides tricyclic compounds and their use in treating medical disorders, such as obesity. Pharmaceutical compositions and methods of making various tricyclic compounds are provided. The compounds are contemplated to have activity against methionyl aminopeptidase 2.
